38568475|t|Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias.
38568475|a|Reactive astrogliosis accompanies the two neuropathological hallmarks of Alzheimer's disease (AD)-Abeta plaques and neurofibrillary tangles-and parallels neurodegeneration in AD and AD-related dementias (ADRD). Thus, there is growing interest in developing imaging and fluid biomarkers of reactive astrogliosis for AD/ADRD diagnosis and prognostication. Monoamine oxidase-B (MAO-B) is emerging as a target for PET imaging radiotracers of reactive astrogliosis. However, a thorough characterization of MAO-B expression in postmortem control and AD/ADRD brains is lacking. We sought to: (1) identify the primary cell type(s) expressing MAO-B in control and AD brains; (2) quantify MAO-B immunoreactivity in multiple brain regions of control and AD donors as a proxy for PET radiotracer uptake; (3) correlate MAO-B level with local AD neuropathological changes, reactive glia, and cortical atrophy; (4) determine whether the MAOB rs1799836 SNP genotype impacts MAO-B expression level; (5) compare MAO-B immunoreactivity across AD/ADRD, including Lewy body diseases (LBD) and frontotemporal lobar degenerations with tau (FTLD-Tau) and TDP-43 (FTLD-TDP). We found that MAO-B is mainly expressed by subpial and perivascular cortical astrocytes as well as by fibrous white matter astrocytes in control brains, whereas in AD brains, MAO-B is significantly upregulated by both cortical reactive astrocytes and white matter astrocytes across temporal, frontal, and occipital lobes. By contrast, MAO-B expression level was unchanged and lowest in cerebellum. Cortical MAO-B expression was independently associated with cortical atrophy and local measures of reactive astrocytes and microglia, and significantly increased in reactive astrocytes surrounding Thioflavin-S+ dense-core Abeta plaques. MAO-B expression was not affected by the MAOB rs1799836 SNP genotype. MAO-B expression was also significantly increased in the frontal cortex and white matter of donors with corticobasal degeneration, Pick's disease, and FTLD-TDP, but not in LBD or progressive supranuclear palsy. These findings support ongoing efforts to develop MAO-B-based PET radiotracers to image reactive astrogliosis in AD/ADRD.
38568475	20	39	monoamine oxidase-B	Gene	4129
38568475	41	46	MAO-B	Gene	4129
38568475	66	87	reactive astrogliosis	Disease	MESH:D005911
38568475	91	110	Alzheimer's disease	Disease	MESH:D000544
38568475	123	132	dementias	Disease	MESH:D003704
38568475	134	155	Reactive astrogliosis	Disease	MESH:D005911
38568475	207	226	Alzheimer's disease	Disease	MESH:D000544
38568475	228	230	AD	Disease	MESH:D000544
38568475	232	237	Abeta	Gene	351
38568475	250	273	neurofibrillary tangles	Disease	MESH:D055956
38568475	288	305	neurodegeneration	Disease	MESH:D019636
38568475	309	311	AD	Disease	MESH:D000544
38568475	316	336	AD-related dementias	Disease	MESH:D000544
38568475	338	342	ADRD	Disease	MESH:D000544
38568475	423	444	reactive astrogliosis	Disease	MESH:D005911
38568475	449	451	AD	Disease	MESH:D000544
38568475	452	456	ADRD	Disease	MESH:D000544
38568475	488	507	Monoamine oxidase-B	Gene	4129
38568475	509	514	MAO-B	Gene	4129
38568475	572	593	reactive astrogliosis	Disease	MESH:D005911
38568475	635	640	MAO-B	Gene	4129
38568475	678	680	AD	Disease	MESH:D000544
38568475	681	685	ADRD	Disease	MESH:D000544
38568475	768	773	MAO-B	Gene	4129
38568475	789	791	AD	Disease	MESH:D000544
38568475	813	818	MAO-B	Gene	4129
38568475	877	879	AD	Disease	MESH:D000544
38568475	940	945	MAO-B	Gene	4129
38568475	963	965	AD	Disease	MESH:D000544
38568475	1012	1028	cortical atrophy	Disease	MESH:D001284
38568475	1056	1060	MAOB	Gene	4129
38568475	1061	1070	rs1799836	SNP	tmVar:rs1799836;VariantGroup:0;CorrespondingGene:4129;RS#:1799836;CorrespondingSpecies:9606
38568475	1092	1097	MAO-B	Gene	4129
38568475	1128	1133	MAO-B	Gene	4129
38568475	1158	1160	AD	Disease	MESH:D000544
38568475	1161	1165	ADRD	Disease	MESH:D000544
38568475	1177	1195	Lewy body diseases	Disease	MESH:D020961
38568475	1197	1200	LBD	Disease	MESH:D020961
38568475	1206	1249	frontotemporal lobar degenerations with tau	Disease	MESH:D057174
38568475	1251	1259	FTLD-Tau	Disease	MESH:D057174
38568475	1265	1271	TDP-43	Disease	MESH:D057177
38568475	1273	1281	FTLD-TDP	Disease	MESH:D057180
38568475	1298	1303	MAO-B	Gene	4129
38568475	1448	1450	AD	Disease	MESH:D000544
38568475	1459	1464	MAO-B	Gene	4129
38568475	1619	1624	MAO-B	Gene	4129
38568475	1691	1696	MAO-B	Gene	4129
38568475	1742	1758	cortical atrophy	Disease	MESH:D001284
38568475	1879	1891	Thioflavin-S	Chemical	MESH:C009462
38568475	1904	1909	Abeta	Gene	351
38568475	1919	1924	MAO-B	Gene	4129
38568475	1960	1964	MAOB	Gene	4129
38568475	1965	1974	rs1799836	SNP	tmVar:rs1799836;VariantGroup:0;CorrespondingGene:4129;RS#:1799836;CorrespondingSpecies:9606
38568475	1989	1994	MAO-B	Gene	4129
38568475	2093	2118	corticobasal degeneration	Disease	MESH:D000088282
38568475	2120	2134	Pick's disease	Disease	MESH:D020774
38568475	2140	2148	FTLD-TDP	Disease	MESH:D057180
38568475	2161	2164	LBD	Disease	MESH:D020961
38568475	2168	2198	progressive supranuclear palsy	Disease	MESH:D013494
38568475	2250	2255	MAO-B	Gene	4129
38568475	2288	2309	reactive astrogliosis	Disease	MESH:D005911
38568475	2313	2315	AD	Disease	MESH:D000544
38568475	2316	2320	ADRD	Disease	MESH:D000544
38568475	Association	MESH:D000544	4129
38568475	Association	MESH:D005911	4129
38568475	Association	MESH:C009462	351
38568475	Association	MESH:D057177	4129
38568475	Association	MESH:D057180	4129
38568475	Association	MESH:D005911	351
38568475	Association	MESH:D003704	4129
38568475	Association	MESH:D020961	4129
38568475	Association	MESH:D057174	4129
38568475	Association	MESH:D001284	4129

